{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Li X"],"funding":["Luo Yuankai-Zishen Yutaiwan-Research Fund for Young Scholars","National Natural Science Foundation of China"],"pagination":["9277"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10247710"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(1)"],"pubmed_abstract":["Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patients. This retrospective study was conducted in the Hospital for Reproductive Medicine affiliated to Shandong University from August 2017 to June 2021. A total of 1774 women with a history of RIF undergoing frozen embryo transfer (FET) were included in this study. All the participants were classified into atosiban or control group: Group A included 677 patients who were administered atosiban intravenously 30 min prior to FET with a dose of 37.5 mg; Group B included 1097 patients who received no atosiban before the transfer. There were no significant differe"],"journal":["Scientific reports"],"pubmed_title":["Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles."],"pmcid":["PMC10247710"],"funding_grant_id":["20190810","82174429"],"pubmed_authors":["Li X","Sheng Y","Lian F","Han X","Du Y","Wang H","Lian Q"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles.","description":"Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patients. This retrospective study was conducted in the Hospital for Reproductive Medicine affiliated to Shandong University from August 2017 to June 2021. A total of 1774 women with a history of RIF undergoing frozen embryo transfer (FET) were included in this study. All the participants were classified into atosiban or control group: Group A included 677 patients who were administered atosiban intravenously 30 min prior to FET with a dose of 37.5 mg; Group B included 1097 patients who received no atosiban before the transfer. There were no significant differe","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jun","modification":"2025-04-19T08:09:02.036Z","creation":"2025-04-19T08:09:02.036Z"},"accession":"S-EPMC10247710","cross_references":{"pubmed":["37286752"],"doi":["10.1038/s41598-023-36286-y"]}}